clonazepam has been researched along with Neurodegenerative Diseases in 10 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sleep disorders and neurodegenerative diseases are commonly encountered in primary care." | 2.53 | Importance of Rapid Eye Movement Sleep Behavior Disorder to the Primary Care Physician. ( Howell, MJ; McCarter, SJ, 2016) |
| "The cornerstone of treatment for all parasomnias is adequate patient and bed partner education." | 2.46 | Parasomnias: an overview. ( Lee-Chiong, T; Matwiyoff, G, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rémi, J | 1 |
| Fernández-Arcos, A | 1 |
| Iranzo, A | 2 |
| Serradell, M | 1 |
| Gaig, C | 1 |
| Santamaria, J | 2 |
| McCarter, SJ | 1 |
| Howell, MJ | 1 |
| Shimohata, T | 1 |
| Inoue, Y | 1 |
| Hirata, K | 1 |
| Abenza Abildúa, MJ | 1 |
| Miralles Martinez, A | 1 |
| Arpa Gutiérrez, FJ | 1 |
| Lores Gutiérrez, V | 1 |
| Algarra Lucas, C | 1 |
| Jimeno Montero, C | 1 |
| Sánchez García, B | 1 |
| Mata Álvarez-Santullano, M | 1 |
| Borrue Fernández, C | 1 |
| Cordero Martín, G | 1 |
| Gutiérrez Cueto, G | 1 |
| Torrecillas Narváez, MD | 1 |
| Thuissard Vasallo, I | 1 |
| Gómez Aceña, A | 1 |
| Tolosa, E | 1 |
| Bodkin, CL | 1 |
| Schenck, CH | 1 |
| Lauterbach, EC | 1 |
| Victoroff, J | 1 |
| Coburn, KL | 1 |
| Shillcutt, SD | 1 |
| Doonan, SM | 1 |
| Mendez, MF | 1 |
| Matwiyoff, G | 1 |
| Lee-Chiong, T | 1 |
| Yamashita, S | 1 |
| Maeda, Y | 1 |
| Ohmori, H | 1 |
| Uchida, Y | 1 |
| Hirano, T | 1 |
| Yonemura, K | 1 |
| Uyama, E | 1 |
| Uchino, M | 1 |
7 reviews available for clonazepam and Neurodegenerative Diseases
| Article | Year |
|---|---|
[Wild dreams and injured bed partners - The REM-sleep-behavior disorder as a precursor of neurodegenerative disorders].
Topics: Aged; Clonazepam; Diagnosis, Differential; Dreams; Electroencephalography; Humans; Male; Neurodegene | 2017 |
Importance of Rapid Eye Movement Sleep Behavior Disorder to the Primary Care Physician.
Topics: Central Nervous System Depressants; Clonazepam; Diagnosis, Differential; GABA Modulators; Humans; Me | 2016 |
Diagnosis, disease notification, and management of rapid eye movement (REM) sleep behavior disorder.
Topics: alpha-Synuclein; Clonazepam; Diagnosis, Differential; Humans; Neurodegenerative Diseases; REM Sleep | 2017 |
The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases.
Topics: Anticonvulsants; Brain; Clonazepam; Dreams; Humans; Neurodegenerative Diseases; Neurotransmitter Age | 2009 |
Rapid eye movement sleep behavior disorder in women: relevance to general and specialty medical practice.
Topics: Clonazepam; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; GABA Modulators; | 2009 |
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzo | 2010 |
Parasomnias: an overview.
Topics: Adolescent; Adult; Age of Onset; Aged; Clonazepam; Female; Humans; Male; Mental Disorders; Middle Ag | 2010 |
3 other studies available for clonazepam and Neurodegenerative Diseases
| Article | Year |
|---|---|
The Clinical Phenotype of Idiopathic Rapid Eye Movement Sleep Behavior Disorder at Presentation: A Study in 203 Consecutive Patients.
Topics: Aged; Aged, 80 and over; Clonazepam; Continuous Positive Airway Pressure; Dementia; Electromyography | 2016 |
Conditions associated with REM sleep behaviour disorder: Description of a hospital series.
Topics: Anticonvulsants; Clonazepam; Female; Humans; Male; Middle Aged; Neurodegenerative Diseases; Polysomn | 2019 |
Pantothenate kinase-associated neurodegeneration initially presenting as postural tremor alone in a Japanese family with homozygous N245S substitutions in the pantothenate kinase gene.
Topics: Acanthocytes; Adult; Anticonvulsants; Asian People; Asparagine; Basal Ganglia; Brain Mapping; Clonaz | 2004 |